Ortivus
1.95 SEK
+35.42 %
Less than 1K followers
ORTI B
First North Stockholm
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Income statement
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Ortivus
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | 50.8 | 107.6 | 94.3 | 104.5 | 84.7 | 80.4 | 73.4 |
| growth-% | 111.6 % | -12.4 % | 10.9 % | -19.0 % | -5.0 % | -8.7 % | |
| EBITDA | -8.5 | 13.9 | 12.7 | 10.2 | -11.9 | -19.5 | -15.9 |
| EBIT | -15.5 | 11.4 | 9.3 | 5.9 | -17.6 | -19.5 | -19.8 |
| Profit before taxes | -16.0 | 11.3 | 9.2 | 5.8 | -18.2 | -24.8 | -21.7 |
| Net income | -16.0 | 11.3 | 9.2 | 5.9 | -18.3 | -24.9 | -21.9 |
| EPS | -0.41 | 0.26 | 0.21 | 0.13 | -0.41 | -0.56 | -0.43 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend ratio | -0.0 % | 0.0 % | 0.0 % | 0.0 % | -0.0 % | -0.0 % | -0.0 % |
Profitability and return on capital
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| EBITDA-% | -16.8 % | 12.9 % | 13.5 % | 9.8 % | -14.1 % | -24.3 % | -21.7 % |
| EBIT-% | -30.4 % | 10.6 % | 9.9 % | 5.6 % | -20.8 % | -24.3 % | -27.0 % |
| ROE | -182.8 % | 57.6 % | 31.3 % | 16.6 % | -105.4 % | 347.3 % | -97.6 % |
| ROI | -45.8 % | 17.0 % | 12.7 % | 6.6 % | -25.1 % | -39.0 % | -30.8 % |